These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A double-blind placebo controlled trial of simvastatin for the treatment of dyslipidaemia in renal allograft recipients. Lepre F; Rigby R; Hawley C; Saltissi D; Brown A; Walsh Z Clin Transplant; 1999 Dec; 13(6):520-5. PubMed ID: 10617243 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of simvastatin in the treatment of hyperlipidemia in uremic patients undergoing hemodialysis treatment]. Fiorini F; Patrone E; Ardu F; Castelluccio A Minerva Urol Nefrol; 1992; 44(2):165-8. PubMed ID: 1411867 [TBL] [Abstract][Full Text] [Related]
7. Hyperlipidemia in renal transplant recipients: natural history and response to treatment. Ong CS; Pollock CA; Caterson RJ; Mahony JF; Waugh DA; Ibels LS Medicine (Baltimore); 1994 Jul; 73(4):215-23. PubMed ID: 8041244 [TBL] [Abstract][Full Text] [Related]
8. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]). Bays HE; Dujovne CA; McGovern ME; White TE; Kashyap ML; Hutcheson AG; Crouse JR; Am J Cardiol; 2003 Mar; 91(6):667-72. PubMed ID: 12633795 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of low-density-lipoprotein lowering with statins. Seidel D; Cremer P Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915367 [No Abstract] [Full Text] [Related]
11. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia]. Martínez-Castelao A Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262 [No Abstract] [Full Text] [Related]